Activated TBK1 phosphorylates IRF3, promoting its nuclear translocation and initiating IFN-α/β transcription, which rapidly recruits CD8+ T cells and NK cells to elicit anti-tumor effects (12, 13). This evidence concerns the gene CD8A and neoplasm.